Flavone-8-acetic acid and interleukin-2 in a method of treating certain cancers
US5096707A · kind A · utility
18Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 15, 1988 |
| Grant date | Mar 17, 1992 |
| Priority date | — |
| Expiry date | Apr 15, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/2013
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A treatment regimen for cancers having cells which are susceptible to an interleukin-2 activated natural killer cell mediated anti-cancer effect, the method comprises administering to a patient an effective amount of a combination of interleukin 2 and flavone-8-acetic acid. The treatment regimen is particularly effective in the treatment of renal carcinoma. Synergistic pharmaceutical compositions are also provided. effective in the treatment of renal carcinoma. Synergistic pharmaceutical compositions are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.